Coronavirus Induced Disease-2019

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-06-01
Clinical Trial Update: Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury [Phase 2]
Phase 2 trial evaluating oral ibrutinib for respiratory failure due to COVID-19 has completed with posted results.